Lexaria Reports 566% Increase in CBD Brain Absorption in Animal Study
Bitget2026/10/15 13:10- Lexaria Bioscience announced results from animal study GLP-1-A26-1 on October 15, 2026, showing improved brain absorption with experimental DehydraTECH-CBD formulations.
- The ALT2 CBD formulation increased mean brain absorption by 566% versus the reference formulation eight hours after dosing.
- All three alternative CBD formulations showed no statistically significant differences in blood plasma absorption versus the reference, supporting potential development.
- The ALT2 semaglutide formulation performed best among alternatives, with no statistically significant difference in blood plasma absorption versus the reference.
- Three new patent applications cover tested formulations, expanding intellectual property options for commercialization.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic spends $3.4 billion to purchase gas-fired power equipment to supply electricity for data centers
In September, Anthropic directly acquired Caterpillar equipment orders worth 3.4 billion USD, securing 1.7 GW of gas generator units, marking the largest single purchase of power generation equipment in AI history. This move bypassed utility middlemen, capturing scarce capacity at prices set years ago with near-term delivery. It is part of Anthropic's plan to invest over 895 billion USD in computing infrastructure by 2045.

Why Nintendo Stock Is One to Watch Ahead of the Holiday Season

A wallet address sold 1.44 million TRX via SunSwap in exchange for 460,000 USDT.

Data: Whales have cumulatively withdrawn approximately 13.4 million USDT from a certain exchange.